SCHEMBL21760537

SCHEMBL21760537

CCOc1ccnc2[nH]c([Si](C)(C)C)c(-c3ccc4c(c3)NCC4)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 4/20 0.49
▸ JAK2 O60674 4/20 0.41
▸ JAK3 P52333 3/20 0.41
▸ S1PR3 Q99500 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CDK9 P50750 3/20 0.34
▸ CCNT1 O60563 2/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CCNA1 P78396 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ ABCC4 O15439 1/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ PTGS1 P23219 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29700827 1.00 S1PR1 (0.49) S1PR1JAK2JAK3S1PR3SMN1; SMN2
SCHEMBL21760536 0.84 S1PR1 (0.46) S1PR1JAK2JAK3S1PR3SMN1; SMN2
SCHEMBL21760535 0.83 CDK9 (0.38) S1PR1JAK2JAK3SMN1; SMN2CDK9
SCHEMBL29700834 0.83 CDK9 (0.38) S1PR1JAK2JAK3SMN1; SMN2CDK9
SCHEMBL21747952 0.78 JAK2 (0.52) S1PR1JAK2JAK3S1PR3CDK9
SCHEMBL21747867 0.77 JAK3 (0.40) JAK3CYP11B2
SCHEMBL30090129 0.77 ALK (0.36) S1PR1JAK2JAK3CDK9SYK
SCHEMBL21760569 0.77 ALK (0.36) S1PR1JAK2JAK3CDK9SYK
SCHEMBL21747908 0.74 JAK3 (0.50) JAK3
SCHEMBL21753142 0.74 CHRM4 (0.37) JAK2JAK3CDK9PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807274-B1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER LEAD DISCOVERY CENTER GMBH (DE) 2022-07-27 — — EP disclosed
WO-2020039060-A1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER LEAD DISCOVERY CENTER GMBH (DE) 2020-02-27 — — WO disclosed
EP-3613738-A1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER Lead Discovery Center GmbH (DE) 2020-02-26 — — EP disclosed
Send feedback